Discover how chronic respiratory failure increases heart disease risk in COPD patients. Learn why early cardiovascular ...

Angiotensin-converting enzyme (ACE) inhibitor therapy may reduce all-cause mortality in idiopathic pulmonary fibrosis (IPF) but not in COPD.

Patients with refractory chronic cough who received twice-daily Haduvio for 21 days had decreases in cough frequency and ...

Discover key Q3 2025 insights from Achieve Life Sciences as they expedite cytisinicline’s FDA approval for nicotine dependence.

Innovations Stem Cell Center, recently named the top U.S. stem-cell therapy provider by Life Sciences Review, offers patients a safe, standardized, and affordable alternative to unregulated overseas ...

A pioneering patient-reported outcome tool, developed by healthcare company Observia with the support of Kingston University, has shown significant promise in predicting the risk of a patient with ...

The American Lung Association Research Institute is investing $22 million to advance research and care for lung disease, ...

The American Lung Association Research Institute is investing $22 million to advance research and care for lung disease, ...

For patients with AECOPD admitted to the ICU, lower eosinophil counts are associated with increased in-hospital mortality.

Positive top-line results from VIBRANT Phase 2 trial of verekitug in CRSwNP reported in September showed statistically ...

Newswatch 16's Justin Gick spoke with a pulmonologist about the signs and symptoms of COPD and when to see a doctor.

Chronic obstructive pulmonary disease (COPD) affects approximately 29 million people in the U.S. and is the fourth leading ...